(19)

(11)

EP 4 363 577 A1

(12)

(43) Date of publication: 08.05.2024 Bulletin 2024/19 (21) Application number: 22833827.3 (22) Date of filing: 26.01.2022

(51) International Patent Classification (IPC):  C12N 15/11(2006.01) A61K 31/713(2006.01) A61P 35/02(2006.01) C12N 15/113(2010.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; A61P 35/02; C12N 15/1138; C12N 2310/14; C12N 2320/31; C12N 2310/315; C12N 2320/11   C-Sets: C12N 2310/321, C12N 2310/3521; C12N 2310/322, C12N 2310/3533; (86) International application number: PCT/US2022/013908 (87) International publication number: WO 2023/277959 (05.01.2023 Gazette 2023/01)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 28.06.2021 US 202117359905 (71) Applicant: bioAffinity Technologies, Inc. San Antonio, TX 78257 (US)	(72) Inventors: ELZI, David J. San Antonio, Texas 78218 (US) BAUTA, William E. San Antonio, Texas 78230 (US) REBEL, Vivienne I. San Antonio, Texas 78255 (US) (74) Representative: van Breda, Jacobus  Octrooibureau Los & Stigter B.V. P.O. Box 20052 1000 HB Amsterdam 1000 HB Amsterdam (NL)